Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Levocetirizine ODT vs IRT in Healthy Japanese Males
NCT03555890Phase 1Completed
- Sponsor
- GSK
- Start
- May 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of levocetirizine in rhinitis (4 arms), sponsored by GSK. Primary endpoints: Area Under the Concentration-time Curve From Time Zero to Last Quantifiable Concentration and Maximum Observed Concentration. Started May 2018; status: completed.
02
Drugs
levocetirizine
03
Conditions
rhinitis
Beyond the preview
Go deeper on NCT03555890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03555890.